Processa Pharmaceuticals Advances Cancer Drug Trials Despite No Recent ASCO Updates

Published 1 days agoPCSA

Processa Pharmaceuticals Advances Cancer Drug Trials Despite No Recent ASCO Updates

As of May 30, 2025, there are no new data reports from Processa Pharmaceuticals presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting regarding their cancer drug development. However, the company has made notable strides in ongoing cancer drug trials, particularly with their NGC-Cap therapy.

In October 2024, Processa kicked off a Phase 2 clinical trial for NGC-Cap, a drug combining PCS6422 and capecitabine, targeted at patients with advanced or metastatic breast cancer. This trial aims to assess the effectiveness of two different doses of NGC-Cap against the standard monotherapy capecitabine. Earlier in July 2024, the FDA granted clearance for Processa's Investigational New Drug application, paving the way for this trial's initiation. Significant positive data was also shared in April 2024 at the American Association for Cancer Research (AACR) Annual Meeting, showing enhanced 5-FU exposure and a favorable safety profile.

Processa Pharmaceuticals has been proactive in its strategic approach. In January 2024, they successfully completed a Phase 1b safety evaluation, which helped establish recommended doses for the Phase 2 trial. Looking ahead, Dr. David Young, President of Research & Development at Processa, planned to present at the World Orphan Drug Congress USA 2025. This presentation will delve into applying FDA's Project Optimus principles to both oncology and rare disease treatment strategies, as reported by Nasdaq.

Share this article

Twitter Facebook LinkedIn

Recent Articles

BigBear.ai Stock Tumbles Amid Financial Challenges and Insider Selling

BigBear.ai Stock Tumbles Amid Financial Challenges and Insider Selling

39 minutes agoBBAI

BigBear.ai's stock has taken a sharp dive, dropping about 24% over four days, raising investor concerns about its performance and future prospects. This comes as the company revealed financial losses and insider sales that seem to overshadow the opportunity for investment. Money Morning brought attention to this notable decline, pointing out the company's recent financial disclosures. The financials paint a concerning picture. In Q4 2024, BigBear.ai reported a hefty net loss of $108 million, largely due to a $93.3 million non-cash charge related to derivatives. Although the revenue rose by 8% to $43.8 million compared to the previous year, it still fell short of analyst expectations. The full-year 2024 figures are similarly grim, with the net loss ballooning to $257.1 million from just $60.4 million in 2023, as per reports from Nasdaq. Looking to the future, BigBear.ai forecasts a full-year 2025 revenue between $160 million and $180 million, which misses the analyst projections of nearly $193.9 million. Additionally, the firm expects negative single-digit million figures in adjusted EBITDA, suggesting further operational losses. Moreover, insider selling following the earnings announcement has drawn concern, with entities linked to AE Industrial Partners offloading over 8.24 million shares, indicating a potential lack of confidence. This sentiment is echoed by several analysts, with Northland Capital Markets and Cantor Fitzgerald adjusting their ratings and price targets, respectively.

EOG Resources Expands with $5.6 Billion Acquisition of Encino Partners

EOG Resources Expands with $5.6 Billion Acquisition of Encino Partners

54 minutes agoEOG

This week, EOG Resources made a major move to bolster its foothold in the Utica shale basin by announcing a $5.6 billion deal to acquire Encino Acquisition Partners. Including debt, this acquisition will bring EOG an additional 675,000 net core acres, increasing its resource portfolio to an impressive 12 billion barrels of oil equivalent. This strategic play is among the latest in EOG's efforts to solidify its presence in key shale regions. Reuters reported that the acquisition clearly demonstrates EOG's focus on expanding its resource base. In addition to expanding its shale holdings, EOG Resources is setting its sights on enhancing shareholder returns. The company plans a debt increase to $5-$6 billion in the next 12 to 18 months, which will support a more than 100% allocation of its free cash flow back to shareholders. This strategy includes a $5 billion extension of its share buyback program and a boost to its dividend, following a strong third-quarter performance where profits exceeded expectations. Supporting this strategy of value creation, EOG recently reported a better-than-expected fourth-quarter adjusted profit of $2.74 per share against analyst predictions of $2.57. This was attributed to a 6.7% rise in quarterly oil production, even in the face of declining oil prices. The company returned $1.3 billion to shareholders in the first quarter of 2025 through dividends and share repurchases, while also announcing a new international oil discovery in Trinidad. This broad strategy reflects EOG's dedication to strategic growth and improving shareholder returns.

JPMorgan Names Former NOAA Chief Scientist to Lead Climate Advisory

JPMorgan Names Former NOAA Chief Scientist to Lead Climate Advisory

JPMorgan Chase has announced the appointment of Dr. Sarah Kapnick, who previously served as the Chief Scientist at NOAA, as the Global Head of Climate Advisory for its Commercial and Investment Bank. This new role places Dr. Kapnick at the helm of guiding clients through complex issues related to climate, energy, biodiversity, and sustainability. Dr. Kapnick's responsibilities will focus on helping JPMorgan's clients navigate opportunities that arise from the transition to a low-carbon economy and assisting them in enhancing their resilience to extreme weather events. According to ESG Dive, her leadership will be a crucial part of the bank's effort to integrate climate science into its advisory services, reflecting a growing demand for sustainable investment strategies in the financial sector. With her return to JPMorgan, Dr. Kapnick brings extensive experience from her time at NOAA, where she directed the agency's science and technology priorities. The appointment signifies JPMorgan's strategic commitment to incorporating climate expertise into its operations, underscoring the broader industry trend of financial institutions embedding climate considerations into their services. Reuters also reported on this significant hire, highlighting the bank's focus on advancing its climate advisory capabilities.

TSMC Shares Trade at $193.32 Amid AI Demand Expectations

TSMC Shares Trade at $193.32 Amid AI Demand Expectations

Taiwan Semiconductor Manufacturing Company (TSMC) is currently trading at $193.32 per share, with a slight decrease of $3.75 or 0.02% from the previous close. The stock opened at $195.85, reaching an intraday high of $196.52 and a low of $190.6 with a trading volume of 11,998,300. Analysts are maintaining their positive outlook for TSMC, seeing strong potential in its AI sector involvement. Barclays has increased its price target to $215, citing TSMC's leading technology and position. Meanwhile, Goldman Sachs has set a more optimistic target of $254 due to the strong demand for AI and advanced node growth, and Citi has adjusted its target to NT$1,150, emphasizing TSMC's strong market position. These developments highlight TSMC's crucial role in the AI-driven semiconductor market. As noted by Nasdaq, the company's strategy to leverage growth in the AI sector continues to inspire confidence among analysts and investors alike, reflecting its robust demand and technological edge.